Managing your iPhone contacts can become a daunting task, especially when you need to delete several entries simultaneously. While iOS lacks a built-in “select all” feature, it does provide a ...

Apple’s latest iPhone software patch, iOS 26.2.1, was released as a relatively small update aimed at improving stability and fixing lingering issues from earlier versions. In the days since its ...

Because the 2026 Winter Games are so spread out, athletes will march in Milan and several other locations. By Victor Mather At the Winter Olympics opening ceremonies on Friday, athletes will march in ...

GitLab Inc. GTLB shares rallied 12.8% in the last trading session to close at $37.4. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Gitlab's results matched analyst estimates, but its growth rate slowed. Some investors seem to believe AI is more of a threat to the company than an opportunity. The stock is cheaper than it's ever ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

Users across Workspace plans can now use Flow to create videos based on a text prompt or images. Users across Workspace plans can now use Flow to create videos based on a text prompt or images. is a ...

If you cannot select multiple emails in Outlook using the Ctrl+Click shortcut, there is a high chance of a discrepancy between the web and desktop versions. In this post, we will discuss this in ...

Elon Musk's Grok, the chatbot developed by his company xAI, acknowledged "lapses in safeguards" on the AI platform that allowed users to generate digitally altered, sexualized photos of minors. The ...

A new study suggests that dementia may be driven in part by faulty blood flow in the brain. Researchers found that losing a key lipid causes blood vessels to become overactive, disrupting circulation ...

In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...